ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -63.85M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-63.85M | (m) |
| 2026-03-31 | (m) | $-49.68M | (m) |
| 2025-12-31 | (m) | $-59.50M | (m) |
| 2025-09-30 | (m) | $-79.61M | (m) |
| 2025-06-30 | (m) | $-121.23M | (m) |
| 2025-03-31 | (m) | $-141.84M | (m) |
| 2024-12-31 | (m) | $-159.49M | (m) |
| 2024-09-30 | (m) | $-195.24M | (m) |
| 2024-06-30 | (m) | $-213.47M | (m) |
| 2024-03-31 | (m) | $-215.06M | (m) |
| 2023-12-31 | (m) | $-225.25M | (m) |
| 2023-09-30 | (m) | $-195.94M | (m) |
| 2023-06-30 | (m) | $-190.92M | (m) |
| 2023-03-31 | (m) | $-195.15M | (m) |
| 2022-12-31 | (m) | $-200.19M | (m) |
| 2022-09-30 | (m) | $-221.50M | (m) |
| 2022-06-30 | (m) | $-232.12M | (m) |
| 2022-03-31 | (m) | $-229.37M | (m) |
| 2021-12-31 | (m) | $-207.28M | (m) |
| 2021-09-30 | (m) | $-190.42M | (m) |
| 2021-06-30 | (m) | $-171.23M | (m) |
| 2021-03-31 | (m) | $-155.47M | (m) |
| 2020-12-31 | (m) | $-146.23M | (m) |
| 2020-09-30 | (m) | $-122.27M | (m) |
| 2020-06-30 | (m) | $-99.50M | (m) |
| 2020-03-31 | (m) | $-81.62M | (m) |
| 2019-12-31 | (m) | $-68.61M | (m) |
| 2019-09-30 | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
| 2018-12-31 | (m) | $-46.45M | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2017-12-31 | (m) | $-42.83M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |